Literature DB >> 10688340

Low TENS treatment on post-stroke paretic arm: a three-year follow-up.

L Sonde1, H Kalimo, S E Fernaeus, M Viitanen.   

Abstract

OBJECTIVE: To determine whether stroke patients with initial increases in arm motor recovery following low-frequency transcutaneous electrical nerve stimulation (low TENS) treatment go on to show long-term benefits. Also whether the same therapy results in long-term improvements in motor function, spasticity or activities of daily living (ADL).
DESIGN: A three-year follow-up study.
SUBJECTS: Twenty-eight stroke patients, who had participated in a randomized trial of daily treatment with low-frequency (1.7 Hz) transcutaneous electrical nerve stimulation (low TENS) on the paretic arm for three months starting 6-12 months after stroke. OUTCOMES: Fugl-Meyer Motor Performance Scale for evaluation of changes in arm motor function. A 6-point Ashworth Scale to measure spasticity. Barthel Index to evaluate performance in ADL.
RESULTS: Motor function of the paretic arm had deteriorated in both treatment and control groups. Increased spasticity was seen in both groups. ADL score remained at a similar level in the low TENS group, whereas the control group had deteriorated during the same time period.
CONCLUSIONS: Low TENS stimulation started 6-12 months after stroke may not have a specific effect on arm motor function years after completion of treatment.

Entities:  

Mesh:

Year:  2000        PMID: 10688340     DOI: 10.1191/026921500673534278

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  8 in total

1.  Hebbian-Type Primary Motor Cortex Stimulation: A Potential Treatment of Impaired Hand Function in Chronic Stroke Patients.

Authors:  Kate Pirog Revill; Marc W Haut; Samir R Belagaje; Fadi Nahab; Daniel Drake; Cathrin M Buetefisch
Journal:  Neurorehabil Neural Repair       Date:  2020-01-24       Impact factor: 3.919

Review 2.  Characterising the Features of 381 Clinical Studies Evaluating Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Relief: A Secondary Analysis of the Meta-TENS Study to Improve Future Research.

Authors:  Mark I Johnson; Carole A Paley; Priscilla G Wittkopf; Matthew R Mulvey; Gareth Jones
Journal:  Medicina (Kaunas)       Date:  2022-06-14       Impact factor: 2.948

3.  Non-pharmacological interventions for the improvement of post-stroke activities of daily living and disability amongst older stroke survivors: A systematic review.

Authors:  Carrie Stewart; Selvarani Subbarayan; Pamela Paton; Elliot Gemmell; Iosief Abraha; Phyo Kyaw Myint; Denis O'Mahony; Alfonso J Cruz-Jentoft; Antonio Cherubini; Roy L Soiza
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

Review 4.  [Evidence-based arm rehabilitation--a systematic review of the literature].

Authors:  T Platz
Journal:  Nervenarzt       Date:  2003-10       Impact factor: 1.214

5.  Frontal and frontoparietal injury differentially affect the ipsilateral corticospinal projection from the nonlesioned hemisphere in monkey (Macaca mulatta).

Authors:  R J Morecraft; J Ge; K S Stilwell-Morecraft; D W McNeal; S M Hynes; M A Pizzimenti; D L Rotella; W G Darling
Journal:  J Comp Neurol       Date:  2015-08-18       Impact factor: 3.215

Review 6.  What is the evidence for physical therapy poststroke? A systematic review and meta-analysis.

Authors:  Janne Marieke Veerbeek; Erwin van Wegen; Roland van Peppen; Philip Jan van der Wees; Erik Hendriks; Marc Rietberg; Gert Kwakkel
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

Review 7.  Emergent properties of neural repair: elemental biology to therapeutic concepts.

Authors:  S Thomas Carmichael
Journal:  Ann Neurol       Date:  2016-04-21       Impact factor: 10.422

8.  Repetitive Peripheral Magnetic Nerve Stimulation (rPMS) as Adjuvant Therapy Reduces Skeletal Muscle Reflex Activity.

Authors:  Volker R Zschorlich; Martin Hillebrecht; Tammam Tanjour; Fengxue Qi; Frank Behrendt; Timo Kirschstein; Rüdiger Köhling
Journal:  Front Neurol       Date:  2019-08-27       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.